1. Home
  2. NICE Guidance
  3. Published Guidance

Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders

Technology appraisal guidance [TA748] Published: 01 December 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 220 KB 01 December 2021  
  • Register of interests PDF 148 KB 01 December 2021  

Final draft guidance

  • Final draft guidance  
  • Final appraisal document PDF 255 KB 04 November 2021  
  • Committee papers PDF 4.11 MB 04 November 2021  
  • Public committee slides PDF 620 KB 04 November 2021  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document (online commenting)  
  • Appraisal consultation document (PDF version) PDF 149 KB 12 February 2021  
  • Committee papers PDF 8.74 MB 12 February 2021  
  • Public committee slides PDF 369 KB 12 February 2021  

Invitation to participate

  • Final scope PDF 161 KB 23 September 2019  
  • Equality impact assessment (Scoping) PDF 127 KB 23 September 2019  
  • NICE's response to comments on the draft scope and provisional stakeholder list PDF 391 KB 23 September 2019  
  • Final stakeholder list PDF 179 KB 24 September 2019  

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators: 1488

  • Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators: 1488  
  • Draft scope pre referral PDF 300 KB 26 November 2018  
  • Draft matrix pre referral PDF 251 KB 12 February 2019